Karuna Therapeutics Investor Relations Material
Latest events
Q3 2023
Karuna Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Karuna Therapeutics Inc
Access all reports
Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurological and psychiatric disorders. The company's research focuses on discovering and utilizing novel pathways for medications that aim to significantly improve the lives of those affected by conditions such as schizophrenia and dementia-related psychosis. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
KRTX
Country
🇺🇸 United States